A randomised controlled intervention trial evaluating the efficacy of a Mediterranean dietary pattern on cognitive function and psychological wellbeing in healthy older adults: the MedLey study

The MedLey study was designed to test the efficacy of a traditional Cretan Mediterranean dietary pattern (MedDiet) on cognitive function and psychological well-being.

**Intervention Group:** Participants in this group were instructed to adopt and maintain a traditional Cretan Mediterranean diet for six months. This dietary pattern emphasizes:

* High consumption of vegetables, fruits, olive oil, legumes, fish, whole grain cereals, nuts, and seeds.

* Low consumption of processed foods, dairy products, red meat, and other vegetable oils (implying a preference for olive oil).

**Control Group:** Participants in the control group were asked to maintain their customary lifestyle and diet for the same six-month period. This served as the comparator to assess the specific effects of the MedDiet intervention.

The study aimed to measure several outcomes:

**Primary Outcome:** Quantitative differences in age-related cognitive performance. This was to be assessed using "latent variables (cognitive constructs) sensitive to normal ageing and diet." These constructs included:

* Speed of processing

* Memory

* Attention

* Executive functions

* Visual spatial ability

* Visuomotor ability

**Secondary Outcomes:** Changes in various biological markers and psychological factors, including:

* Biomarkers of inflammation

* Biomarkers of oxidative stress

* Lipid metabolism markers

* Glucose levels

* Insulin levels

* Blood flow velocity

* Psychological well-being factors, such as stress, sleep quality, anxiety, and depression.

The study aimed to recruit a specific population to ensure generalizability to healthy older adults.

**Sample Size:** A total of 166 healthy Australian men and women were planned for recruitment.

**Population:** Participants were healthy older adults, specifically aged 65 years and above.

**Inclusion Criteria:**

* Aged 65 years and above.

* Healthy, meaning they had normal cognitive function (implying no diagnosed cognitive impairment or dementia).

* Proficient in the English language, likely to ensure accurate understanding of instructions and completion of cognitive assessments.

**Setting:** Participants were recruited from metropolitan Adelaide, South Australia.

The abstract describes the *types* of measures planned but does not specify the exact instruments or scales.

**Cognitive Function:** The primary outcome was to be measured by "latent variables (cognitive constructs) sensitive to normal ageing and diet." This suggests the use of a battery of standardized neuropsychological tests designed to assess specific cognitive domains. While the specific tests are not named, the constructs targeted include:

* Speed of processing

* Memory

* Attention

* Executive functions

* Visual spatial ability

* Visuomotor ability

These would typically involve tasks like reaction time tests, memory recall tests, attention span tasks, problem-solving puzzles, and visual perception tests.

**Biomarkers:** Secondary outcomes included "biomarkers of inflammation, oxidative stress, lipid metabolism, glucose, insulin, blood flow velocity." These would typically be measured through blood samples (for inflammation markers like C-reactive protein, oxidative stress markers, cholesterol panels, glucose, insulin) and potentially non-invasive techniques for blood flow velocity (e.g., ultrasound).

**Psychological Well-being:** Secondary outcomes also included "psychological well-being factors (i.e. stress, sleep, anxiety, depression)." These are typically measured using validated self-report questionnaires or scales, such as the Perceived Stress Scale, Pittsburgh Sleep Quality Index, Hospital Anxiety and Depression Scale, or similar instruments.

Without the full paper, the precise names of the tests, assays, or questionnaires used remain unknown.

The MedLey study was designed as a rigorous intervention trial to establish a cause-and-effect relationship between diet and cognitive outcomes.

**Study Design:** This was a 6-month, randomized controlled, 2-cohort parallel group intervention trial.

* **Randomized Controlled Trial (RCT):** This is considered the "gold standard" for clinical research because it minimizes bias and allows for strong conclusions about cause and effect. Participants are randomly assigned to either the intervention (MedDiet) or control (usual diet) group.

* **2-Cohort Parallel Group:** This means there were two distinct groups (cohorts) that ran in parallel throughout the study duration. One group received the intervention, and the other received the control, and they were compared at the end. This is in contrast to a crossover design where participants switch between groups.

* **Intervention Trial:** The study actively intervened by asking one group to change their diet, rather than just observing existing dietary patterns (as in an observational study).

**Randomisation:** Participants were "randomly allocated" to either the experimental (MedDiet) or control group.

* **How it works:** Randomisation ensures that, on average, any unmeasured or unknown confounding factors (like genetics, lifestyle habits not related to diet, or socioeconomic status) are evenly distributed between the groups. This means that any differences observed between the groups at the end of the study are more likely to be due to the intervention itself, rather than pre-existing differences between the participants.

* **Why it matters:** Without randomisation, if, for example, healthier individuals tended to choose the MedDiet group, any observed benefits could be attributed to their initial health status rather than the diet. Randomisation helps to balance these characteristics, strengthening the causal inference.

**Blinding:** The abstract does not explicitly mention blinding. In dietary intervention studies, it is extremely difficult, if not impossible, to blind participants to their dietary assignment (they know what they are eating). It might be possible to blind the researchers who are assessing outcomes (e.g., the neuropsychologists administering cognitive tests or laboratory technicians analyzing blood samples), but this is not stated.

* **Why it matters:** Lack of blinding, especially for participants, can introduce bias. Participants in the intervention group might expect to feel better or perform better, leading to a "placebo effect" or reporting bias. Similarly, unblinded researchers might unconsciously influence participants or interpret results in a way that favors the intervention.

**Washout Periods:** Not applicable to a parallel group design. Washout periods are typically used in crossover designs to ensure the effects of one intervention have completely disappeared before the next intervention begins.

**Duration:** The intervention period was six months.

* **Why it matters:** A six-month duration is often considered sufficient for dietary changes to exert measurable effects on physiological markers and potentially cognitive function. Shorter durations might not allow enough time for changes to manifest, while longer durations can face challenges with participant adherence and retention.

**Assessment Frequency:** Initial assessment was conducted at baseline, and then repeated every three months (meaning assessments at baseline, 3 months, and 6 months).

* **Why it matters:** Multiple assessment points allow researchers to track changes over time within each group and to see if the intervention's effects are gradual or more immediate. It also helps to identify if effects are sustained throughout the intervention period.

**Statistical Approach:** The abstract does not detail the specific statistical methods planned, but given the design, it would likely involve comparing changes in cognitive performance and secondary outcomes between the MedDiet and control groups over the six-month period, using methods appropriate for repeated measures data (e.g., mixed-effects models or repeated measures ANOVA).

* **Why it matters:** Appropriate statistical analysis is crucial to determine if observed differences are statistically significant (unlikely to have occurred by chance) and to estimate the magnitude of any effects.

**What this design can and cannot prove:**

**Can Prove:** As a randomized controlled trial, the MedLey study was designed to provide strong evidence for a **cause-and-effect relationship** between adopting a Mediterranean dietary pattern and changes in cognitive function and psychological well-being in healthy older adults. By randomly assigning participants, the researchers aimed to minimize confounding variables, making it more likely that any observed differences were directly attributable to the diet.

**Cannot Prove:**

* **Generalizability beyond the studied population:** While robust for its specific population, the findings might not directly apply to younger adults, individuals with pre-existing cognitive impairment, or populations with different genetic backgrounds or dietary habits.

* **Long-term effects:** A six-month study cannot definitively prove the very long-term effects (e.g., over several years) of the MedDiet on cognitive decline or disease prevention.

* **Mechanism of action:** While secondary outcomes included biomarkers, the study design itself might not fully elucidate the precise biological mechanisms through which the MedDiet might influence cognition.

* **Perfect adherence:** Dietary interventions often struggle with perfect participant adherence. While efforts are typically made to monitor diet, it's challenging to ensure participants strictly follow the prescribed diet for the entire duration, which could dilute the observed effects.

* **Blinding limitations:** The inherent difficulty in blinding participants to a dietary intervention means that some level of participant expectation bias (placebo effect) or reporting bias could still be present, even if researchers are blinded to outcome assessment.

**Major Methodological Weaknesses (based on abstract):**

The abstract describes a robust design. The primary inherent weakness for *any* dietary intervention RCT is the practical impossibility of fully blinding participants to their dietary assignment. This means that participant expectations could potentially influence self-reported outcomes or even performance on cognitive tasks. However, this is a common challenge in nutrition research, not a specific flaw in the MedLey study's design itself. The abstract does not report any other obvious methodological weaknesses in the *design*.

This abstract describes the *design* of the MedLey study and does not report any findings or results. The study was designed to investigate the efficacy of a Mediterranean dietary pattern on cognitive function and psychological well-being in healthy older adults. Therefore, no specific effect sizes, confidence intervals, or p-values can be provided from this abstract.

As this abstract describes the study design and does not report results, no effect magnitudes can be provided. The study aimed to quantify differences in cognitive performance and psychological well-being, but the outcomes of these measurements are not available in this text.

The authors acknowledge that, at the time of publication of this study protocol, there was a lack of randomized evidence validating the positive associations between the Mediterranean dietary pattern and improved cognitive outcomes in healthy older adult populations (≥65 years and above). This study was designed to address that gap.

Beyond the authors' stated rationale for the study, a critical reader would note the following limitations inherent to the study's design and the information available in the abstract:

**Lack of Results:** The most significant limitation of this